Our network of scientific talents, thought leaders and inventors

From our very first grant—to the American Red Cross more than a century ago—through to today’s vast array of initiatives, The Rockefeller Foundation has built a reputation as a trailblazer that convenes unlikely partnerships and sparks innovations for transformative change. Our list of greatest achievements is long. We founded the modern field of public health, developed a vaccine to help control yellow fever, and worked to combat hookworm in the U.S. and malaria in Italy, funded urban visionary Jane Jacobs, and catalyzed a Green Revolution. The Rockefeller Foundation is the initiator of the PTFI Project.

The University of Trento is an Italian university located in Trento and nearby Rovereto. It has been able to achieve considerable results in didactics, research, and international relations according to CENSIS and the Italian Ministry of Education. Seerave is collaborating with Nicola Segata, affiliated with the University of Trento and strongly engaged in the metagenomic analysis of the data of the PRIMM Study.

Gebert Rüf Stiftung was established by entrepreneur Heinrich Gebert as a science and innovation foundation. Its objective is to promote «Switzerland as a top location for business and as a place to live» (purpose article). As a private funding agency guided by its mission statement «making science effective», it supports entrepreneurial projects which are committed to achieving an impact.

Rising Tide Group is an organization with a strong philanthropic mission. It is based in Schaffhausen Switzerland, however truly global in its reach and activities. Our philanthropic work is organized in two entities – the Rising Tide Foundation (RTF) and the Rising Tide Foundation for Clinical Cancer Research (RTFCCR). Both are charitable, non-profit organizations established in 2010. The Rising Tide GmbH is the service company for both foundations and responsible for the promotion and the offering of philanthropic services of the foundations, for the financial prosperity and operative well-being of the organizations, and for the sustainable income generation.

Melanoma Research Alliance is a leading funder of melanoma research, committed to accelerating scientific discovery and the development of new treatments and diagnostics for this deadly skin cancer. 100% of donations to the Melanoma Research Alliance go to research funding.

The Université de Montréal is a French-language public research university in Montreal, Quebec, Canada. It is ranked fourth in the country in terms of volume of research activities. Seerave is collaborating with the Routy Lab within the Université de Montréal.

Based on a novel biosensing approach called the “Molecular Pendulum”, Arma Bioscience has developed a rapid, versatile sensor platform to enable continuous monitoring of a multitude of physiological markers. The Arma platform’s sensing tips are compatible with saliva, blood, urine, sweat, and tears, and can be quickly developed to detect for various health indications. Seerave placed a seed investment into Arma Biosceince with the conviction that their expertise around label-free biosensor technology could be key in enabling wearable biosensors in the future.

Xsensio develops the unique Lab-on-Skin™​ sensing platform to sense in real-time biochemical information at the surface of the skin, providing unprecedented real-time information about our health and wellness, in a simple and non-invasive way. The Xsensio Lab-on-Skin™ sensing chip relies on a unique, highly-miniaturized sensing platform. By leveraging semiconductor properties, our sensing platform unleashes a whole new set of possibilities in continuous health monitoring.

HexagonFab’s award-winning technology is very different from state-of-the-art methods and enables us to offer significantly simpler and more affordable biomolecular interaction analysis. HexagonFab’s Bolt will enable SME biotechs and large pharma to perform measurements in-house, thereby significantly reducing turnaround time, while at the same time providing a universally applicable fast screening tool.

The University of Strathclyde is a leading international technological university. Established in 1796 as a place of 'useful learning,' the University remains committed to research, teaching, useful learning and employability. Seerave is collaborating with Damion Corrigan and team of the University of Strathclyde in the context of the Deep Immunity project.

The University of Toronto (UofT) is among the world's most prestigious universities. Founded in 1827, it offers over 700 undergraduate degree and 200 postgraduate degree programmes to a cohort of almost 60,000 students. With a longstanding reputation for innovation and research, the University of Toronto was the birthplace of such ground-breaking scientific moments. Seerave is collaborating with Shana Kelley and her team at the University of Toronto in the context of the Deep Immunity Project.

University Medical Center Groningen is part of the University of Groningen. It's mission is "The future of health asks for innovation to help understand why some fall ill and others do not. For the development of innovative diagnostics, treatments and sustainable health systems." Seerave is collaborating with Rinse Weersma and Geke Hospers from UMCG in the context of the PRIMM Study.

A vault for humanity | The Microbiota Vault Supporting One Health Preserving microbial diversity To forever secure the basis of the naturally evolved diversity of the microbiota important to humankind to support health globally.

King's is ranked in the top 10 UK universities in the world (QS World Rankings 2021) and based in the heart of London. With nine faculties, institutes and schools of study and five Medical Research Council centres, King's offers world-class teaching and research. Seerave is collaborating with Tim Spector and Veronique Bataille from the Department of Twin Research & Genetic Epidemiology at KCL in the context of the PRIMM Study.

BiomeSense has created the first technology to overhaul microbiome data generation & analysis (1) GutLab At-home Automated Laboratory – The GutLab is a proprietary “smart bathroom” technology for microbiome tracking, combining a user-friendly interface and advanced internal fluidics to produce high-frequency, fully standardized data (2) MetaBiome Bioinformatics Platform – MetaBiome is an AI-powered microbiome biomarker discovery engine, designed by Rob Knight @ UCSD, that uses advanced signal processing algorithms to enable microbiome analysis far beyond anything possible today In an industry first, these solutions form a single comprehensive platform – the GutLab continuously feeds ultra-high-resolution data into MetaBiome’s database where it is analyzed using MetaBiome AI. This platform generates far superior microbiome data than ever before possible, revolutionizing the development of microbiome biomarkers, precision therapeutics, and consumer products.

Micronoma’s approach to addressing this unmet need utilizes cell-free microbial DNA (cf-mbDNA) biomarkers and machine learning technology to achieve early detection and classification of cancer from minimally invasive liquid biopsy samples. Human tissues, including tumors, are extensively colonized by taxonomically diverse microbes. Intra-tumoral microbial activity and events of cellular turnover and trafficking contribute to shedding of microbial nucleic acids into the bloodstream where they can be captured and detected by a simple blood draw. This is all based on their patent pending Oncobiota™ platform which reveals the cancer-related microbiome with unparalleled specificity and sensitivity. This new minimally invasive and precise microbiome-driven liquid biopsy™ method can detect cancer in its earliest stages, unlike tests that only focus on the human genome, epigenome, or cancer mutation.

The University of Texas MD Anderson Cancer Center (MD Anderson) was established by the Texas State Legislature in 1941and is a free-standing, degree-granting health institution within The University of Texas System. Mission areas include patient care, research, education, and prevention. Seerave is collaborating with Jennifer Wargo and Jennifer McQuade in the context of the controlled dietary interventions study.

The University of California, San Diego was founded in 1960 and is part of the University of California association. UCSD is one of the most prestigious universities in the world. Seerave is collaborating with Rob Knight and Jack Gilbert from UCSD in multiple projects including the Microsetta initative and the start-ups Micronoma and BiomeSense that both emerged out of UCSD.

The Weizmann Institute of Science is one of the world's leading multidisciplinary basic research institutions in the natural and exact sciences. It is located in Rehovot, Israel, just south of Tel Aviv. Seerave is collaborating with Eran Segal and his Team from Weizmann Institute in the Personalized Nutrition Study.

Geneva University Hospitals is the largest university hospital in Switzerland, providing high quality and professional medical services, medical training and specific researches. Seerave is collaborating with Thomas Gurry from HUG on the Hippie Study.

The École polytechnique fédérale de Lausanne (EPFL) is a public research university located in Lausanne, Switzerland.It specializes in natural sciences and engineering. It is one of the two Swiss Federal Institutes of Technology, with three main missions: education, research and innovation. Seerave is collaborating with Marcel Salaté from EPFL on the AI for Nutrition initative.

The Technion – Israel Institute of Technology is a public research university located in Haifa, Israel. Established in 1912 under the dominion of the Ottoman Empire, the Technion is the oldest university in the country. The Technion is ranked as the top university in both Israel and the Middle East, and in the top 100 universities in the world in the Academic Ranking of World Universities of 2019. Seerave is collaborating with Naama Geva-Zarorski on a project investigating Microbiome-Derived Metabolites.

Gustave Roussy is the first leader cancer-research hospital in Europe and ranked among the top 5 best specialized hospitals in the world . It is a centre for high quality patient care, research and teaching. It is highly-known for the treatment of (among others): skin cancers like melanoma, breast cancer, and lung cancer. Seerave is collaborating with Laurence Zitvogel and Guido Kroemer on multiple research projects.